A recent scientific paper suggests that a drug typically administered to animals called Fenbendazole (Ref.) may have strong anti-cancer properties. In this paper, the authors suggest that drugs such as Fenbendazole reactivate the p53 protein that has been called the Guardian of the Genome that functions as a tumor suppressor.
While Fenbendazole may, indeed, prove to be beneficial for treating many types of cancers, it appears to have the best chance of success in addressing:
• Non-small Cell Lung Cancer Cells (NSCLC)cancertreatmentsresearch.com, “A Drug For Animals Now Taken By Humans For Cancer: Fenbendazole,” Dec 14, 2020
• Prostate Cancer and taxane-resistant prostate cancer cells